MK-5475, an inhaled soluble guanylate cyclase stimulator, for treatment of pulmonary arterial hypertension: the INSIGNIA-PAH study

Onno W. Akkerman

G. B. Migliori

Alberto L. Garcia-Basteiro

European Respiratory Journal 2400109; DOI: 10.1183/13993003.00109-2024 Published 14 November 2024

Transmission continues to drive the tuberculosis (TB) and drug-resistant TB epidemics, making infection control an essential component for public health agencies worldwide [1–3]. Transmission of TB is complex, influenced by factors linked to patient behaviour, form of disease, the exposed individual, the microbe, and the environment [3–6]. Each year more than 10…

留言 (0)

沒有登入
gif